Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares OutstandingShort-Term Debt repayments
Ratios

Cue Biopharma (CUE) Leases (2019 - 2025)

Historic Leases for Cue Biopharma (CUE) over the last 7 years, with Q3 2025 value amounting to $4.6 million.

  • Cue Biopharma's Leases rose 1408.03% to $4.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 1408.03%. This contributed to the annual value of $4.4 million for FY2024, which is 3088.72% down from last year.
  • According to the latest figures from Q3 2025, Cue Biopharma's Leases is $4.6 million, which was up 1408.03% from $5.1 million recorded in Q2 2025.
  • In the past 5 years, Cue Biopharma's Leases ranged from a high of $9.9 million in Q2 2022 and a low of $1.3 million during Q4 2022
  • Moreover, its 5-year median value for Leases was $5.6 million (2024), whereas its average is $6.1 million.
  • Its Leases has fluctuated over the past 5 years, first plummeted by 8674.8% in 2022, then soared by 38638.46% in 2023.
  • Over the past 5 years, Cue Biopharma's Leases (Quarter) stood at $9.8 million in 2021, then tumbled by 86.75% to $1.3 million in 2022, then surged by 386.38% to $6.3 million in 2023, then crashed by 30.89% to $4.4 million in 2024, then grew by 5.31% to $4.6 million in 2025.
  • Its Leases was $4.6 million in Q3 2025, compared to $5.1 million in Q2 2025 and $3.6 million in Q1 2025.